Evaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvante

Introducción: el cáncer de mama, es una enfermedad heterogénea, con diferentes grados de agresividad, que dependen de su expresión fenotípica, destacándose el comportamiento de los receptores hormonales y Her2, que contribuyen finalmente a la respuesta al tratamiento y pronóstico de la enfermedad. M...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2023
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
spa
OAI Identifier:
oai:repository.urosario.edu.co:10336/41492
Acceso en línea:
https://repository.urosario.edu.co/handle/10336/41492
Palabra clave:
Cáncer de mama
Receptor de progesterona
Quimioterapia neoadyuvante
Breast Neoplasms
Progesterone receptor
Neoadjuvant chemotherapy
Rights
License
Attribution-NonCommercial-ShareAlike 4.0 International
id EDOCUR2_b5379c8112a6a9bfdd30559c85044740
oai_identifier_str oai:repository.urosario.edu.co:10336/41492
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
dc.title.none.fl_str_mv Evaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvante
dc.title.TranslatedTitle.none.fl_str_mv Prognostic evaluation of the progesterone hormone receptor in patients with luminal breast cancer treated with neoadjuvant chemotherapy
title Evaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvante
spellingShingle Evaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvante
Cáncer de mama
Receptor de progesterona
Quimioterapia neoadyuvante
Breast Neoplasms
Progesterone receptor
Neoadjuvant chemotherapy
title_short Evaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvante
title_full Evaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvante
title_fullStr Evaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvante
title_full_unstemmed Evaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvante
title_sort Evaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvante
dc.contributor.advisor.none.fl_str_mv Cuello López, Javier Mauricio
dc.subject.none.fl_str_mv Cáncer de mama
Receptor de progesterona
Quimioterapia neoadyuvante
topic Cáncer de mama
Receptor de progesterona
Quimioterapia neoadyuvante
Breast Neoplasms
Progesterone receptor
Neoadjuvant chemotherapy
dc.subject.keyword.none.fl_str_mv Breast Neoplasms
Progesterone receptor
Neoadjuvant chemotherapy
description Introducción: el cáncer de mama, es una enfermedad heterogénea, con diferentes grados de agresividad, que dependen de su expresión fenotípica, destacándose el comportamiento de los receptores hormonales y Her2, que contribuyen finalmente a la respuesta al tratamiento y pronóstico de la enfermedad. Métodos: el objetivo principal de este estudio analítico, retrospectivo de cohorte histórica fue evaluar el valor pronostico del receptor progesterona en pacientes diagnosticadas con cáncer de mama luminal manejadas con quimioterapia neoadyuvante. Resultados: en un tiempo de seguimiento de 7,5 años, se estudiaron 178 pacientes, en su mayoría con fenotipo ER+/PR- (79,2%), sin embargo, no se observaron diferencias estadísticamente significativas en estos grupos a excepción del índice de enfermedad residual RDBN en el análisis multivariado para la evaluación pronostica del receptor de progesterona. Conclusión: En pacientes con cáncer de mama subtipo luminal tratadas con quimioterapia neoadyuvante, el estado del receptor de progesterona no se asoció como factor pronóstico de supervivencia.
publishDate 2023
dc.date.accessioned.none.fl_str_mv 2023-11-08T13:10:13Z
dc.date.available.none.fl_str_mv 2023-11-08T13:10:13Z
dc.date.created.none.fl_str_mv 2023-10-31
dc.type.none.fl_str_mv bachelorThesis
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.document.none.fl_str_mv Trabajo de grado
dc.type.spa.none.fl_str_mv Trabajo de grado
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/41492
url https://repository.urosario.edu.co/handle/10336/41492
dc.language.iso.none.fl_str_mv spa
language spa
dc.rights.*.fl_str_mv Attribution-NonCommercial-ShareAlike 4.0 International
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_14cb
dc.rights.acceso.none.fl_str_mv Bloqueado (Texto referencial)
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
rights_invalid_str_mv Attribution-NonCommercial-ShareAlike 4.0 International
Bloqueado (Texto referencial)
http://creativecommons.org/licenses/by-nc-sa/4.0/
http://purl.org/coar/access_right/c_14cb
dc.format.extent.none.fl_str_mv 61 pp
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad del Rosario
Universidad CES. Facultad de Medicina
Universidad de CES. Facultad de medicina
dc.publisher.department.none.fl_str_mv Escuela de Medicina y Ciencias de la Salud
dc.publisher.program.none.fl_str_mv Especialización en Epidemiología
publisher.none.fl_str_mv Universidad del Rosario
Universidad CES. Facultad de Medicina
Universidad de CES. Facultad de medicina
institution Universidad del Rosario
dc.source.bibliographicCitation.none.fl_str_mv Kamińska, Marzena; Ciszewski, Tomasz; Łopacka-Szatan, Karolina; Miotła, Paweł; Starosławska, Elzbieta (2015) Breast cancer risk factors. En:Przeglad Menopauzalny; Vol. 14; No. 3; pp. 196 - 202; Disponible en: 10.5114/pm.2015.54346.
Weiss, Anna; Chavez-MacGregor, Mariana; Lichtensztajn, Daphne Y.; Yi, Min; Tadros, Audree; Hortobagyi, Gabriel N.; Giordano, Sharon H.; Hunt, Kelly K.; Mittendorf, Elizabeth A. (2018) Validation study of the American joint committee on cancer eighth edition prognostic stage compared with the anatomic stage in breast cancer. En:JAMA Oncology; Vol. 4; No. 2; pp. 203 - 209; Disponible en: 10.1001/jamaoncol.2017.4298.
Troxell, Megan L; Gupta, Tanya (2023) Neoadjuvant Therapy in Histologic Changes and Clinical Implications. En:Surgical Pathology; Vol. 15; No. 1; pp. 57 - 75; Elsevier Inc.; Disponible en: https://doi.org/10.1016/j.path.2021.11.004. Disponible en: 10.1016/j.path.2021.11.004.
Tan, Puay Hoon; Ellis, Ian; Allison, Kimberly; Brogi, Edi; Fox, Stephen B.; Lakhani, Sunil; Lazar, Alexander J.; Morris, Elizabeth A.; Sahin, Aysegul; Salgado, Roberto; Sapino, Anna; Sasano, Hironobu; Schnitt, Stuart; Sotiriou, Christos; van Diest, Paul; White, Valerie A.; Lokuhetty, Dilani; Cree, Ian A. (2020) The 2019 World Health Organization classification of tumours of the breast. En:Histopathology; Vol. 77; No. 2; pp. 181 - 185; Disponible en: 10.1111/his.14091.
Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Martin, Miguel; Press, Michael; Mackey, John; Glaspy, John; Chan, Arlene; Pawlicki, Marek; Pinter, Tamas; Valero, Vicente; Liu, Mei-Ching; Sauter, Guido; Minckwitz, Gunter von; Visco, Frances; Bee, Valerie; Buyse, Marc; Bendahmane, Belguendouz; Tabah-Fisch, Isabelle; Lindsay, Mary-Ann; Riva, Alessandro; F, John Crown .; Group*, Breast Cancer International Research (2011) Adjuvant Trastuzumab in HER2-Positive Breast Cancer. En:New England Journal of Medicine; Vol. 365; pp. 687 - 696;
Agnese, Doreen; Burns, Jennifer; Giordano, Sharon H; Kumar, Rashmi (2019) Breast Cancer. En:Nccn; Vol. 2; No. 0; pp. 215 - 215;
De Cicco, Paola; Catani, Maria Valeria; Gasperi, Valeria; Sibilano, Matteo; Quaglietta, Maria; Savini, Isabella (2019) Nutrition and breast cancer: A literature review on prevention, treatment and recurrence. En:Nutrients; Vol. 11; No. 7; pp. 1 - 28; Disponible en: 10.3390/nu11071514.
De Azambuja, E.; Cardoso, F.; De Castro, G.; Colozza, M.; Mano, M. S.; Durbecq, V.; Sotiriou, C.; Larsimont, D.; Piccart-Gebhart, M. J.; Paesmans, M. (2007) Ki-67 as prognostic marker in early breast cancer: A meta-analysis of published studies involving 12 155 patients. En:British Journal of Cancer; Vol. 96; No. 10; pp. 1504 - 1513; Disponible en: 10.1038/sj.bjc.6603756.
Varsanik, Mary A; Shubeck, Sarah P (2023) De. Vol. 103; pp. 83 - 92; Disponible en: 10.1016/j.suc.2022.08.005.
Niemeyer Hultstrand, Jenny; Gemzell-Danielsson, Kristina; Kallner, Helena Kopp; Lindman, Henrik; Wikman, Per; Sundström-Poromaa, Inger (2022) Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15–34 years of age: A nationwide register-based study. En:The Lancet Regional Health; Vol. 21; Disponible en: 10.1016/j.lanepe.2022.100470.
Horwitz, Kathryn B.; Sartorius, Carol A. (2020) Progesterone and progesterone receptors in breast cancer: Past, present, future. En:Journal of Molecular Endocrinology; Vol. 65; No. 1; pp. T49 - T63; Disponible en: 10.1530/JME-20-0104.
Lee, Jin Sun; Yost, Susan E.; Yuan, Yuan (2020) Neoadjuvant treatment for triple negative breast cancer: Recent progresses and challenges. En:Cancers; Vol. 12; No. 6; Disponible en: 10.3390/cancers12061404.
Lashen, Ayat G.; Toss, Michael S.; Mongan, Nigel P.; Green, Andrew R.; Rakha, Emad A. (2023) The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long-term follow-up. En:Cancer; No. December 2022; pp. 1183 - 1194; Disponible en: 10.1002/cncr.34655.
Lin, Nancy U.; Claus, Elizabeth; Sohl, Jessica; Razzak, Abdul R.; Arnaout, Amal; Winer, Eric P. (2006) Sites of Distant Relapse and Clinical Outcomes in Patients with Metastatic Triple-Negative Breast Cancer: High Incidence of Central Nervous System Metastases. En:Bone; Vol. 23; No. 1; pp. 1 - 7; 6176321972; Disponible en: 10.1002/cncr.23930.Sites.
Wolff, Antonio C.; Hammond, M. Elizabeth H.; Hicks, David G.; Dowsett, Mitch; McShane, Lisa M.; Allison, Kimberly H.; Allred, Donald C.; Bartlett, John M.S.; Bilous, Michael; Fitzgibbons, Patrick; Hanna, Wedad; Jenkins, Robert B.; Mangu, Pamela B.; Paik, Soonmyung; Perez, Edith A.; Press, Michael F.; Spears, Patricia A.; Vance, Gail H.; Viale, Giuseppe; Hayes, Daniel F. (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast. En:Journal of Clinical Oncology; Vol. 31; No. 31; pp. 3997 - 4013; Disponible en: 10.1200/JCO.2013.50.9984.
Derakhshan, Fatemeh; Reis-Filho, Jorge S. (2021) Pathogenesis of Triple-Negative Breast Cancer. En:Annual Review of Pathology: Mechanisms of Disease; Vol. 17; pp. 181 - 204; Disponible en: 10.1146/annurev-pathol-042420-093238.
Rivera, Donna R.; Ganz, Patricia A.; Weyrich, Meghan S.; Bandos, Hanna; Melnikow, Joy (2018) Chemotherapy-Associated Peripheral Neuropathy in Patients with Early-Stage Breast Cancer: A Systematic Review. En:Journal of the National Cancer Institute; Vol. 110; No. 2; Disponible en: 10.1093/jnci/djx140.
Waks, Adrienne G.; Winer, Eric P. (2019) Breast Cancer Treatment: A Review. En:JAMA; Vol. 321; No. 3; pp. 288 - 300; Disponible en: 10.1001/jama.2018.19323.
Ross, Jeffrey S.; Slodkowska, Elzbieta A.; Symmans, W. Fraser; Pusztai, Lajos; Ravdin, Peter M.; Hortobagyi, Gabriel N. (2009) The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine. En:The Oncologist; Vol. 14; No. 4; pp. 320 - 368; Disponible en: 10.1634/theoncologist.2008-0230.
Grabinski, Victoria F.; Brawley, Otis W. (2022) Disparities in Breast Cancer. En:Obstetrics and Gynecology Clinics of North America; Vol. 49; No. 1; pp. 149 - 165; Elsevier Inc.; Disponible en: https://doi.org/10.1016/j.ogc.2021.11.010. Disponible en: 10.1016/j.ogc.2021.11.010.
Dowsett, Mitch; Cuzick, Jack; Wale, Chris; Howell, Tony; Houghton, Joan; Baum, Michael (2005) Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: An hypothesis-generating study. En:Journal of Clinical Oncology; Vol. 23; No. 30; pp. 7512 - 7517; Disponible en: 10.1200/JCO.2005.01.4829.
Luporsi, Elisabeth; André, Fabrice; Spyratos, Frédérique; Martin, Pierre Marie; Jacquemier, Jocelyne; Penault-Llorca, Frédérique; Tubiana-Mathieu, Nicole; Sigal-Zafrani, Brigitte; Arnould, Laurent; Gompel, Anne; Egele, Caroline; Poulet, Bruno; Clough, Krishna B.; Crouet, Hubert; Fourquet, Alain; Lefranc, Jean Pierre; Mathelin, Carole; Rouyer, Nicolas; Serin, Daniel; Spielmann, Marc; Haugh, Margaret; Chenard, Marie Pierre; Brain, Etienne; De Cremoux, Patricia; Bellocq, Jean Pierre (2012) Ki-67: Level of evidence and methodological considerations for its role in the clinical management of breast cancer: Analytical and critical review. En:Breast Cancer Research and Treatment; Vol. 132; No. 3; pp. 895 - 915; Disponible en: 10.1007/s10549-011-1837-z.
Kunkler, Ian H; Williams, Linda J; Jack, Wilma; Cameron, David A; Dixon, Michael (2021) Abstract GS2-03: Prime 2 randomised trial (postoperative radiotherapy in minimum-risk elderly): Wide local excision and adjuvant hormonal therapy +/- whole breast irradiation in women =/> 65 years with early invasive breast cancer: 10 year results. En:Cancer Research; Vol. 81; No. 4_Supplement; pp. GS2 - 03-GS2-03; Disponible en: https://doi.org/10.1158/1538-7445.SABCS20-GS2-03. Disponible en: 10.1158/1538-7445.SABCS20-GS2-03.
Allison, Kimberly H.; Hammond, M. Elizabeth H.; Dowsett, Mitchell; McKernin, Shannon E.; Carey, Lisa A.; Fitzgibbons, Patrick L.; Hayes, Daniel F.; Lakhani, Sunil R.; Chavez-MacGregor, Mariana; Perlmutter, Jane; Perou, Charles M.; Regan, Meredith M.; Rimm, David L.; Symmans, W. Fraser; Torlakovic, Emina E.; Varella, Leticia; Viale, Giuseppe; Weisberg, Tracey F.; McShane, Lisa M.; Wolff, Antonio C. (2020) Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. En:Journal of Clinical Oncology; Vol. 38; No. 12; pp. 1346 - 1366; Disponible en: 10.1200/JCO.19.02309.
Barzaman, Khadijeh; Karami, Jafar; Zarei, Zeinab; Hosseinzadeh, Aysooda; Kazemi, Mohammad Hossein; Moradi-Kalbolandi, Shima; Safari, Elahe; Farahmand, Leila (2020) Breast cancer: Biology, biomarkers, and treatments. En:International Immunopharmacology; Vol. 84; No. April; Disponible en: 10.1016/j.intimp.2020.106535.
Chen, Chunfa; Zhang, Yuling; Huang, Ziyi; Wu, Jundong; Huang, Wenhe; Zhang, Guojun (2019) Decrease in the Ki67 index during neoadjuvant chemotherapy predicts favorable relapse-free survival in patients with locally advanced breast cancer. En:Cancer Biology and Medicine; Vol. 16; No. 3; pp. 575 - 586; Disponible en: 10.20892/j.issn.2095-3941.2018.0423.
Medina, Mauricio A.; Oza, Goldie; Sharma, Ashutosh; Arriaga, L. G.; Hernández, José Manuel Hernández; Rotello, Vincent M.; Ramirez, Jose Tapia (2020) Triple-negative breast cancer: A review of conventional and advanced therapeutic strategies. En:International Journal of Environmental Research and Public Health; Vol. 17; No. 6; pp. 1 - 32; Disponible en: 10.3390/ijerph17062078.
Fei, Fei; Siegal, Gene P.; Wei, Shi (2022) Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers. En:Clinical Breast Cancer; Vol. 22; No. 7; pp. e788 - e797; Elsevier Inc.; Disponible en: https://doi.org/10.1016/j.clbc.2022.07.001. Disponible en: 10.1016/j.clbc.2022.07.001.
Edge, Stephen B.; Compton, Carolyn C. (2010) The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. En:Annals of Surgical Oncology; Vol. 17; No. 6; pp. 1471 - 1474; Disponible en: 10.1245/s10434-010-0985-4.
Sheibani, Mohammad; Azizi, Yaser; Shayan, Maryam; Nezamoleslami, Sadaf; Eslami, Faezeh; Farjoo, Mohammad Hadi; Dehpour, Ahmad Reza (2022) Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches. En:Cardiovascular Toxicology; Vol. 22; No. 4; pp. 292 - 310; Springer US; Disponible en: https://doi.org/10.1007/s12012-022-09721-1. Disponible en: 10.1007/s12012-022-09721-1.
Jafari, Seyed Hamed; Saadatpour, Zahra; Salmaninejad, Arash; Momeni, Fatemeh; Mokhtari, Mojgan; Nahand, Javid Sadri; Rahmati, Majid; Mirzaei, Hamed; Kianmehr, Mojtaba (2018) Breast cancer diagnosis: Imaging techniques and biochemical markers. En:Journal of Cellular Physiology; Vol. 233; No. 7; pp. 5200 - 5213; Disponible en: 10.1002/jcp.26379.
Di Nardo, Paola; Lisanti, Camilla; Garutti, Mattia; Buriolla, Silvia; Alberti, Martina; Mazzeo, Roberta; Puglisi, Fabio (2022) Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects. En:Expert Opinion on Drug Safety; Vol. 21; No. 11; pp. 1341 - 1355; Taylor & Francis; Disponible en: https://doi.org/10.1080/14740338.2022.2151584. Disponible en: 10.1080/14740338.2022.2151584.
Emens, Leisha A (2018) Breast Cancer Immunotherapy: Facts and Hopes. En:Clinical Cancer Research; Vol. 24; No. 3; pp. 511 - 520; Disponible en: file:///C:/Users/Carla%0ACarolina/Desktop/Artigos%0Apara%0Aacrescentar%0Ana%0Aqualificação/The%0Aimpact%0Aof%0Abirth%0Aweight%0Aon%0Acardiovascular%0Adisease%0Arisk%0Ain. Disponible en: 10.1158/1078-0432.CCR-16-3001.Breast.
Shaaban, Abeer M.; Provenzano, Elena (2022) Receptor Status after Neoadjuvant Therapy of Breast Cancer: Significance and Implications. En:Pathobiology; Vol. 89; No. 5; pp. 297 - 308; Disponible en: 10.1159/000521880.
O’Brien, Katie M; Cole, Stephen R; Tse, Chiu-Kit; Perou, Charles M; Carey, Lisa A; Foulkes, William D; Dressler, Lynn G.; Geradts, Joseph; Millikan, Robert C (2011) Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. En:Bone; Vol. 23; No. 1; pp. 1 - 7; 6176321972; Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf. Disponible en: 10.1158/1078-0432.CCR-10-1533.Intrinsic.
Russo, Jose; Moral, Raquel; Balogh, Gabriela A.; Mailo, Daniel; Russo, Irma H. (2005) The protective role of pregnancy in breast cancer. En:Breast Cancer Research; Vol. 7; No. 3; pp. 131 - 142; Disponible en: 10.1186/bcr1029.
International Agency for Research on Cancer (2018) Estimated number of incident cases stomach, both sexes, all ages. Vol. 33; No. 0; pp. 800 - 800; Disponible en: https://gco.iarc.fr/today/online-analysis-multi-bars?v=2018&mode=population&mode_population=countries&population=900&populations=900&key=total&sex=0&cancer=7&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_item.
Yin, Li; Duan, Jiang Jie; Bian, Xiu Wu; Yu, Shi Cang (2020) Triple-negative breast cancer molecular subtyping and treatment progress. En:Breast Cancer Research; Vol. 22; No. 1; pp. 1 - 13; Breast Cancer Research; Disponible en: 10.1186/s13058-020-01296-5.
Rastogi, Priya; Anderson, Stewart J.; Bear, Harry D.; Geyer, Charles E.; Kahlenberg, Morton S.; Robidoux, André; Margolese, Richard G.; Hoehn, James L.; Vogel, Victor G.; Dakhil, Shaker R.; Tamkus, Deimante; King, Karen M.; Pajon, Eduardo R.; Wright, Mary Johanna; Robert, Jean; Paik, Soonmyung; Mamounas, Eleftherios P.; Wolmark, Norman (2008) Preoperative chemotherapy: Updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. En:Journal of Clinical Oncology; Vol. 26; No. 5; pp. 778 - 785; Disponible en: 10.1200/JCO.2007.15.0235.
Harbeck, Nadia; Penault-Llorca, Frédérique; Cortes, Javier; Gnant, Michael; Houssami, Nehmat; Poortmans, Philip; Ruddy, Kathryn; Tsang, Janice; Cardoso, Fatima (2019) Breast cancer. En:Nature Reviews Disease Primers; Vol. 5; No. 1; 0123456789; Disponible en: 10.1038/s41572-019-0111-2.
Raj-Kumar, Praveen Kumar; Liu, Jianfang; Hooke, Jeffrey A.; Kovatich, Albert J.; Kvecher, Leonid; Shriver, Craig D.; Hu, Hai (2019) PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B. En:Scientific Reports; Vol. 9; No. 1; pp. 1 - 13; Disponible en: 10.1038/s41598-019-44339-4.
Loibl, Sibylle; Gianni, Luca (2017) HER2-positive breast cancer. En:The Lancet; Vol. 389; No. 10087; pp. 2415 - 2429; Elsevier Ltd; Disponible en: http://dx.doi.org/10.1016/S0140-6736(16)32417-5. Disponible en: 10.1016/S0140-6736(16)32417-5.
Moskowitz, Chaya S.; Chou, Joanne F.; Wolden, Suzanne L.; Bernstein, Jonine L.; Malhotra, Jyoti; Friedman, Danielle Novetsky; Mubdi, Nidha Z.; Leisenring, Wendy M.; Stovall, Marilyn; Hammond, Sue; Smith, Susan A.; Henderson, Tara O.; Boice, John D.; Hudson, Melissa M.; Diller, Lisa R.; Bhatia, Smita; Kenney, Lisa B.; Neglia, Joseph P.; Begg, Colin B.; Robison, Leslie L.; Oeffinger, Kevin C. (2014) Breast cancer after chest radiation therapy for childhood cancer. En:Journal of Clinical Oncology; Vol. 32; No. 21; pp. 2217 - 2223; Disponible en: 10.1200/JCO.2013.54.4601.
Chang, Jung Min; Leung, Jessica W.T.; Moy, Linda; Ha, Su Min; Moon, Woo Kyung (2020) Axillary nodal evaluation in breast cancer: State of the art. En:Radiology; Vol. 295; No. 3; pp. 500 - 515; Disponible en: 10.1148/radiol.2020192534.
Silber, Jeffrey H.; Rosenbaum, Paul R.; Clark, Amy S.; Giantonio, Bruce J.; Ross, Richard N.; Teng, Yun; Wang, Min; Niknam, Bijan A.; Ludwig, Justin M.; Wang, Wei; Even-Shoshan, Orit; Fox, Kevin R. (2013) Characteristics associated with differences in survival among black and white women with breast cancer. En:Jama; Vol. 310; No. 4; pp. 389 - 397; Disponible en: 10.1001/jama.2013.8272.
Patani, Neill; Martin, Lesley Ann; Dowsett, Mitch (2013) Biomarkers for the clinical management of breast cancer: International perspective. En:International Journal of Cancer; Vol. 133; No. 1; pp. 1 - 13; Disponible en: 10.1002/ijc.27997.
Sharma, Anita; Ives, Charlotte (2022) Management of breast cancer: basic principles. En:Surgery (United Kingdom); Vol. 40; No. 2; pp. 113 - 120; Elsevier Ltd; Disponible en: https://doi.org/10.1016/j.mpsur.2021.11.020. Disponible en: 10.1016/j.mpsur.2021.11.020.
Deng, Chu Xia (2006) BRCA1: Cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. En:Nucleic Acids Research; Vol. 34; No. 5; pp. 1416 - 1426; Disponible en: 10.1093/nar/gkl010.
Bauer, Anderson (2023) Radiation Treatment for Breast Cancer. En:Surgical Clinics of North America; Vol. 103; No. 1; pp. 187 - 199; Elsevier Inc.; Disponible en: https://doi.org/10.1016/j.suc.2022.08.015. Disponible en: 10.1016/j.suc.2022.08.015.
Dieci, Maria V; Orieto, Enrico; Dominici, Massimo; Conte, Pierfranco; Guarner, Valentina (2014) Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities. En:The Oncologist; pp. 805 - 813;
Li, Lun; Han, Dongdong; Wang, Xiaowei; Wang, Quan; Tian, Jinhui; Yao, Jia; Yuan, Liqin; Qian, Ke; Zou, Qiongyan; Yi, Wenjun; Zhou, Enxiang; Yang, Kehu (2017) Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: A systematic review and meta-analysis. En:Future Oncology; Vol. 13; No. 11; pp. 1021 - 1034; Disponible en: 10.2217/fon-2016-0428.
Fei, Li, MD; Bei, Wang, MD; Hongyu, Ding, MD; Hongjun, Sun, MD (2018) Sonographic Features of Triple Negative Breast Cancer. En:Advanced Ultrasound in Diagnosis and Therapy; Vol. 2; No. 1; pp. 18 - 18; 0000000000; Disponible en: 10.37015/audt.2018.180005.
Dauphine, Christine; Moazzez, Ashkan; Neal, Jasmin C.; Chlebowski, Rowan T.; Ozao-Choy, Junko (2020) Single Hormone Receptor-Positive Breast Cancers Have Distinct Characteristics and Survival. En:Annals of Surgical Oncology; Vol. 27; No. 12; pp. 4687 - 4694; Springer International Publishing; Disponible en: https://doi.org/10.1245/s10434-020-08898-5. Disponible en: 10.1245/s10434-020-08898-5.
Watkins, Elyse J. (2019) Overview of breast cancer. En:Journal of the American Academy of Physician Assistants; Vol. 32; No. 10; pp. 13 - 17; Disponible en: 10.1097/01.JAA.0000580524.95733.3d.
Keenan, Tanya; Moy, Beverly; Mroz, Edmund A.; Ross, Kenneth; Niemierko, Andrzej; Rocco, James W.; Isakoff, Steven; Ellisen, Leif W.; Bardia, Aditya (2015) Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrence. En:Journal of Clinical Oncology; Vol. 33; No. 31; pp. 3621 - 3627; Disponible en: 10.1200/JCO.2015.62.2126.
Kim, Byoung Hyuck; Shin, Kyung Hwan; Chie, Eui Kyu; Kim, Jin Ho; Kim, Kyubo; Hwang, Ki Tae; Kim, Jongjin; Choi, In Sil; Park, Jin Hyun; Kim, Suzy (2020) Identifying long-term survival candidates among patients with isolated locoregionally recurrent breast cancer: Implications of the use of systemic chemotherapy. En:Journal of Breast Cancer; Vol. 23; No. 3; pp. 279 - 290; 0000000171618; Disponible en: 10.4048/jbc.2020.23.e31.
Wang, Huan; Mao, Xiaoyun (2020) Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer. En:Drug Design, Development and Therapy; Vol. 14; pp. 2423 - 2433; Disponible en: 10.2147/DDDT.S253961.
Prat, Aleix; Perou, Charles M. (2011) Deconstructing the molecular portraits of breast cancer. En:Molecular Oncology; Vol. 5; No. 1; pp. 5 - 23; Disponible en: 10.1016/j.molonc.2010.11.003.
Tian, Hao; Ma, Dandan; Tan, Xuanni; Yan, Wenting; Wu, Xiujuan; He, Cheng; Zhong, Ling; Zhang, Yan; Yu, Bingjie; Zhang, Yi; Qi, Xiaowei (2021) Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review. En:Frontiers in Pharmacology; Vol. 12; No. December; pp. 1 - 13; Disponible en: 10.3389/fphar.2021.770663.
Li, Zhuo; Wei, Hongrui; Li, Siyan; Wu, Pei; Mao, Xiaoyun (2022) The Role of Progesterone Receptors in Breast Cancer. No. January; pp. 305 - 314;
Cserni, G; Quinn, Cecily M; Foschini, Maria Pia; Bianchi, Simonetta; Callagy, Grace; Chmielik, Ewa; Decker, Thomas; Fend, Falko; Diest, Paul J Van; Ellis, Ian O (2021) Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis. En:Cancers; pp. 1 - 23;
Carey, Lisa A.; Dees, E. Claire; Sawyer, Lynda; Gatti, Lisa; Moore, Dominic T.; Collichio, Frances; Ollila, David W.; Sartor, Carolyn I.; Graham, Mark L.; Perou, Charles M. (2007) The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes. En:Clinical Cancer Research; Vol. 13; No. 8; pp. 2329 - 2334; Disponible en: 10.1158/1078-0432.CCR-06-1109.
Finkelman, Brian S.; Zhang, Huina; Hicks, David G.; Turner, Bradley M. (2023) The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations. En:Cancers; Vol. 15; No. 3; Disponible en: 10.3390/cancers15030808.
Voduc, K David; Cheang, Maggie C U; Tyldesley, Scott; Gelmon, Karen; Nielsen, Torsten O (2023) Breast Cancer Subtypes and the Risk of Local and Regional Relapse. En:Journal of Clinical Oncology; Vol. 28; No. 10; Disponible en: 10.1200/JCO.2009.24.9284.
Coughlin, Steven S. (2019) Social determinants of breast cancer risk, stage, and survival. En:Breast Cancer Research and Treatment; Vol. 177; No. 3; pp. 537 - 548; Springer US; 0123456789; Disponible en: https://doi.org/10.1007/s10549-019-05340-7. Disponible en: 10.1007/s10549-019-05340-7.
Eisenhauer, E. A.; Therasse, P.; Bogaerts, J.; Schwartz, L. H.; Sargent, D.; Ford, R.; Dancey, J.; Arbuck, S.; Gwyther, S.; Mooney, M.; Rubinstein, L.; Shankar, L.; Dodd, L.; Kaplan, R.; Lacombe, D.; Verweij, J. (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). En:European Journal of Cancer; Vol. 45; No. 2; pp. 228 - 247; Elsevier Ltd; Disponible en: http://dx.doi.org/10.1016/j.ejca.2008.10.026. Disponible en: 10.1016/j.ejca.2008.10.026.
Zhang, Song; Zhang, Dong; Yi, Shanhong; Gong, Mingfu; Lu, Caibao; Cai, Yuanqing; Tang, Xuefeng; Zou, Liguang (2017) The relationship of lymphatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: A systematic review and meta-analysis. En:Oncotarget; Vol. 8; No. 2; pp. 2863 - 2873; Disponible en: 10.18632/oncotarget.13752.
Sun, Yi Sheng; Zhao, Zhao; Yang, Zhang Nv; Xu, Fang; Lu, Hang Jing; Zhu, Zhi Yong; Shi, Wen; Jiang, Jianmin; Yao, Ping Ping; Zhu, Han Ping (2017) Risk factors and preventions of breast cancer. En:International Journal of Biological Sciences; Vol. 13; No. 11; pp. 1387 - 1397; Disponible en: 10.7150/ijbs.21635.
Lambertini, Matteo; Pinto, Ana Catarina; Ameye, Lieveke; Jongen, Lynn; Del Mastro, Lucia; Puglisi, Fabio; Poggio, Francesca; Bonotto, Marta; Floris, Giuseppe; Van Asten, Kathleen; Wildiers, Hans; Neven, Patrick; De Azambuja, Evandro; Paesmans, Marianne; Azim, Hatem A. (2016) The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients. En:British Journal of Cancer; Vol. 115; No. 12; pp. 1471 - 1478; Nature Publishing Group; Disponible en: http://dx.doi.org/10.1038/bjc.2016.359. Disponible en: 10.1038/bjc.2016.359.
Shaikh, Naseer Ahmed; Rajput, M. Jawaid Aqeel; Samo, Rukhsana; Soomro, Rasheed Ahmed (2018) Breast Cancer. En:The Professional Medical Journal; Vol. 21; No. 02; pp. 373 - 376; Disponible en: 10.29309/tpmj/2014.21.02.1986.
Cortazar, Patricia; Zhang, Lijun; Untch, Michael; Mehta, Keyur; Costantino, Joseph P.; Wolmark, Norman; Bonnefoi, Hervé; Cameron, David; Gianni, Luca; Valagussa, Pinuccia; Swain, Sandra M.; Prowell, Tatiana; Loibl, Sibylle; Wickerham, D. Lawrence; Bogaerts, Jan; Baselga, Jose; Perou, Charles; Blumenthal, Gideon; Blohmer, Jens; Mamounas, Eleftherios P.; Bergh, Jonas; Semiglazov, Vladimir; Justice, Robert; Eidtmann, Holger; Paik, Soonmyung; Piccart, Martine; Sridhara, Rajeshwari; Fasching, Peter A.; Slaets, Leen; Tang, Shenghui; Gerber, Bernd; Geyer, Charles E.; Pazdur, Richard; Ditsch, Nina; Rastogi, Priya; Eiermann, Wolfgang; Von Minckwitz, Gunter (2014) Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis. En:The Lancet; Vol. 384; No. 9938; pp. 164 - 172; Disponible en: 10.1016/S0140-6736(13)62422-8.
Kashyap, Dharambir; Pal, Deeksha; Sharma, Riya; Garg, Vivek Kumar; Goel, Neelam; Koundal, Deepika; Zaguia, Atef; Koundal, Shubham; Belay, Assaye (2022) Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. En:BioMed Research International; Vol. 2022; Disponible en: 10.1155/2022/9605439.
Pathmanathan, Nirmala; Balleine, Rosemary L.; Jayasinghe, Upali W.; Bilinski, Kellie L.; Provan, Pamela J.; Byth, Karen; Bilous, A. Michael; Salisbury, Elizabeth L.; Boyages, John (2014) The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. En:Journal of Clinical Pathology; Vol. 67; No. 3; pp. 222 - 228; Disponible en: 10.1136/jclinpath-2013-201793.
Dine, Jennifer; Deng, Chu Xia (2013) Mouse models of BRCA1 and their application to breast cancer research. En:Cancer and Metastasis Reviews; Vol. 32; No. 1-2; pp. 25 - 37; 1055501294037; Disponible en: 10.1007/s10555-012-9403-7.
Foulkes, William D.; Grainge, Matthew J.; Rakha, Emad A.; Green, Andrew R.; Ellis, Ian O. (2009) Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status. En:Breast Cancer Research and Treatment; Vol. 117; No. 1; pp. 199 - 204; Disponible en: 10.1007/s10549-008-0102-6.
Teal, Stephanie; Edelman, Alison (2021) Contraception Selection, Effectiveness, and Adverse Effects: A Review. En:JAMA; Vol. 326; No. 24; pp. 2507 - 2518; Disponible en: 10.1001/jama.2021.21392.
Tan, Shirong; Fu, Xin; Xu, Shouping; Qiu, Pengfei; Lv, Zhidong; Xu, Yingying; Zhang, Qiang (2021) Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy. En:Pathology and Oncology Research; Vol. 27; No. December; pp. 1 - 16; Disponible en: 10.3389/pore.2021.1609972.
Hou, Yanjun; Peng, Yan; Li, Zaibo (2022) Update on prognostic and predictive biomarkers of breast cancer. En:Seminars in Diagnostic Pathology; Vol. 39; No. 5; pp. 322 - 332; Elsevier Inc.; Disponible en: https://doi.org/10.1053/j.semdp.2022.06.015. Disponible en: 10.1053/j.semdp.2022.06.015.
Lin, Canling; Cui, Jiajun; Peng, Zhen; Qian, Kai; Wu, Runwen; Cheng, Yimin; Yin, Weihua (2022) Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis. En:European Journal of Medical Research; Vol. 27; No. 1; pp. 1 - 11; BioMed Central; Disponible en: https://doi.org/10.1186/s40001-022-00839-0. Disponible en: 10.1186/s40001-022-00839-0.
Dunn, Barbara K.; Agurs-Collins, Tanya; Browne, Doris; Lubet, Ronald; Johnson, Karen A. (2010) Health disparities in breast cancer: Biology meets socioeconomic status. En:Breast Cancer Research and Treatment; Vol. 121; No. 2; pp. 281 - 292; Disponible en: 10.1007/s10549-010-0827-x.
Tonellotto, Fabiana; Bergmann, Anke; Abrahao, Karen de Souza; Sales de Aguiar, Suzana; Adeodato Bello, Marcelo; Santos Thuler, Luiz Claudio (2019) Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer. En:European Journal of Breast Health; Vol. 15; No. 2; pp. 76 - 84; Disponible en: 10.5152/ejbh.2019.4414.
Masood, Shahla (2016) Neoadjuvant chemotherapy in breast cancers. Disponible en: 10.1177/1745505716677139.
Łukasiewicz, Sergiusz; Czeczelewski, Marcin; Forma, Alicja; Baj, Jacek; Sitarz, Robert; Stanisławek, Andrzej (2021) Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review. En:Cancers; Vol. 13; No. 17; pp. 4287 - 4287; Disponible en: https://www.mdpi.com/2072-6694/13/17/4287. Disponible en: 10.3390/cancers13174287.
Zhou, Liheng; Xu, Shuguang; Yin, Wenjin; Lin, Yanpin; Du, Yueyao; Jiang, Yiwei; Wang, Yaohui; Zhang, Jie; Wu, Ziping; Lu, Jinsong (2017) Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: A prospective, single arm, phase II study. En:Oncotarget; Vol. 8; No. 45; pp. 79305 - 79314; Disponible en: 10.18632/oncotarget.17954.
Thakkar, Jigisha P.; Mehta, Divyesh G. (2011) A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative. En:The Oncologist; Vol. 16; No. 3; pp. 276 - 285; Disponible en: 10.1634/theoncologist.2010-0302.
Liu, Yin; He, Min; Zuo, Wen Jia; Hao, Shuang; Wang, Zhong Hua; Shao, Zhi Ming (2021) Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement. En:Frontiers in Oncology; Vol. 11; No. April; pp. 1 - 7; Disponible en: 10.3389/fonc.2021.585613.
Freelander, Allegra; Brown, Lauren J; Parker, Andrew; Segara, Davendra; Portman, Neil; Lau, Brandon; Lim, Elgene (2021) Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer.
Palma, Giuseppe; Frasci, Giuseppe; Chirico, Andrea; Esposito, Emanuela; Siani, Claudio; Saturnino, Carmela; Arra, Claudio; Ciliberto, Gennaro; Giordano, Antonio; D'Aiuto, Massimiliano (2015) Triple negative breast cancer: Looking for the missing link between biology and treatments. En:Oncotarget; Vol. 6; No. 29; pp. 26560 - 26574; Disponible en: 10.18632/oncotarget.5306.
Giuliano, Armando E.; Edge, Stephen B.; Hortobagyi, Gabriel N. (2018) Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. En:Annals of Surgical Oncology; Vol. 25; No. 7; pp. 1783 - 1785; Springer International Publishing; Disponible en: https://doi.org/10.1245/s10434-018-6486-6. Disponible en: 10.1245/s10434-018-6486-6.
Feng, Yixiao; Spezia, Mia; Huang, Shifeng; Yuan, Chengfu; Zeng, Zongyue; Zhang, Linghuan; Ji, Xiaojuan; Liu, Wei; Huang, Bo; Luo, Wenping; Liu, Bo; Lei, Yan; Du, Scott; Vuppalapati, Akhila; Luu, Hue H.; Haydon, Rex C.; He, Tong Chuan; Ren, Guosheng (2018) Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. En:Genes and Diseases; Vol. 5; No. 2; pp. 77 - 106; Elsevier Ltd; Disponible en: https://doi.org/10.1016/j.gendis.2018.05.001. Disponible en: 10.1016/j.gendis.2018.05.001.
Hortobagyi, Gabriel N; Edge, Stephen B; Giuliano, Armando (2018) New and Important Changes in the TNM Staging System for Breast Cancer. En:American Society of Clinical Oncology Educational Book; No. 38; pp. 457 - 467; Disponible en: 10.1200/edbk_201313.
Shien, Tadahiko; Iwata, Hiroji (2020) Adjuvant and neoadjuvant therapy for breast cancer. En:Japanese Journal of Clinical Oncology; Vol. 50; No. 3; pp. 225 - 229; Disponible en: 10.1093/jjco/hyz213.
Al‐rashdan, Abdulla; Deban, Melina; Quan, May Lynn; Cao, Jeffrey Q. (2022) Locoregional Management of Breast Cancer: A Chronological Review. En:Current Oncology; Vol. 29; No. 7; pp. 4647 - 4664; Disponible en: 10.3390/curroncol29070369.
Killelea, Brigid K.; Yang, Vicky Q.; Wang, Shi Yi; Hayse, Brandon; Mougalian, Sarah; Horowitz, Nina R.; Chagpar, Anees B.; Pusztai, Lajos; Lannin, Donald R. (2015) Racial differences in the use and outcome of neoadjuvant chemotherapy for breast cancer: Results From the National Cancer Data Base. En:Journal of Clinical Oncology; Vol. 33; No. 36; pp. 4267 - 4275; Disponible en: 10.1200/JCO.2015.63.7801.
Leon-Ferre, Roberto A.; Hieken, Tina J; Boughey, Judy C (2021) The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer. En:Annals of Surgical Oncology; Vol. 28; No. 4; pp. 2111 - 2119; Disponible en: 10.1245/s10434-020-09480-9.
Tsang, Julia Y S; Tse, Gary M (2020) Molecular Classification of Breast Cancer. Vol. 27; No. 1;
Özdemir, Özlem; Zengel, Baha; Çavdar, Demet Kocatepe; Yilmaz, Cengiz; Durusoy, Raika (2022) Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients. En:European Journal of Breast Health; Vol. 18; No. 2; pp. 167 - 171; Disponible en: 10.4274/ejbh.galenos.2022.2022-1-4.
Brawley, Otis W.; Lansey, Dina George (2023) Disparities in Breast Cancer Outcomes and How to Resolve Them. En:Hematology/Oncology Clinics of North America; Vol. 37; No. 1; pp. 1 - 15; Disponible en: 10.1016/j.hoc.2022.08.002.
Giammarile, Francesco; Vidal-Sicart, Sergi; Paez, Diana; Pellet, Olivier; Enrique, Estrada Lobato; Mikhail-Lette, Miriam; Morozova, Olga; Maria Camila, Navarro Marulanda; Diana Ivonne, Rodríguez Sanchez; Delgado Bolton, Roberto C.; Valdés Olmos, Renato A.; Mariani, Giuliano (2022) Sentinel Lymph Node Methods in Breast Cancer. En:Seminars in Nuclear Medicine; Vol. 52; No. 5; pp. 551 - 560; Disponible en: 10.1053/j.semnuclmed.2022.01.006.
Kaufman, Cary S (2019) Increasing Role of Oncoplastic Surgery for Breast Cancer. : Current Oncology Reports;
Yerushalmi, Rinat; Woods, Ryan; Ravdin, Peter M.; Hayes, Malcolm M.; Gelmon, Karen A. (2010) Ki67 in breast cancer: prognostic and predictive potential. En:The Lancet Oncology; Vol. 11; No. 2; pp. 174 - 183; Elsevier Ltd; Disponible en: http://dx.doi.org/10.1016/S1470-2045(09)70262-1. Disponible en: 10.1016/S1470-2045(09)70262-1.
Mohamed, Adel Mahjoub Musa; Alshammari, Fatimah Khalifah Ayed; Aloyatyfi, Razan Fahad Saleh; Alenazi, Khawlah Hammed Mamlooh; Alwuwaili, Amjad Mofareh S (2020) The Relationship between Hormonal Contraception and Breast Cancer. En:Archivepp.Com; Vol. 11; No. 4; pp. 124 - 129; Disponible en: https://archivepp.com/storage/models/article/EtiuefwVvngqexAAD2Xy3cVrHw1yg8mgwdJeKyvsgcR9IWRCtkcpw8z6Sjp6/the-relationship-between-hormonal-contraception-and-breast-cancer.pdf.
Allison, Kimberly H.; Hammond, M. Elizabeth H.; Dowsett, Mitchell; McKernin, Shannon E.; Carey, Lisa A.; Fitzgibbons, Patrick L.; Hayes, Daniel F.; Lakhani, Sunil R.; Chavez-MacGregor, Mariana; Perlmutter, Jane; Perou, Charles M.; Regan, Meredith M.; Rimm, David L.; Symmans, W. Fraser; Torlakovic, Emina E.; Varella, Leticia; Viale, Giuseppe; Weisberg, Tracey F.; McShane, Lisa M.; Wolff, Antonio C. (2020) Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/college of American pathologists guideline update. En:Archives of Pathology and Laboratory Medicine; Vol. 144; No. 5; pp. 545 - 563; Disponible en: 10.5858/arpa.2019-0904-SA.
Diana, Anna; Carlino, Francesca; Buono, Giuseppe; Antoniol, Giuliano; Famiglietti, Vincenzo; De Angelis, Carmine; Carrano, Simone; Piccolo, Antonio; De Vita, Ferdinando; Ciardiello, Fortunato; Daniele, Bruno; Arpino, Grazia; Orditura, Michele (2022) Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis. En:Frontiers in Oncology; Vol. 12; No. March; pp. 1 - 8; Disponible en: 10.3389/fonc.2022.813462.
Byrski, T.; Huzarski, T.; Dent, R.; Marczyk, E.; Jasiowka, M.; Gronwald, J.; Jakubowicz, J.; Cybulski, C.; Wisniowski, R.; Godlewski, D.; Lubinski, J.; Narod, S. A. (2014) Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. En:Breast Cancer Research and Treatment; Vol. 147; No. 2; pp. 401 - 405; Disponible en: 10.1007/s10549-014-3100-x.
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/37208b3b-f4f2-48e3-9eeb-ccf6d3036ca4/download
https://repository.urosario.edu.co/bitstreams/8a7c580f-66f9-4044-85c2-b3ddb33c6817/download
https://repository.urosario.edu.co/bitstreams/c2ee0dc9-dbe7-4996-a62f-0dd652d4d239/download
https://repository.urosario.edu.co/bitstreams/140b15d4-9017-40c5-98d7-19bd1afd239b/download
https://repository.urosario.edu.co/bitstreams/538f9059-b27e-4969-bc2b-bdb85c449f9e/download
https://repository.urosario.edu.co/bitstreams/06f13e0c-5fa8-436b-b81a-6f8ec1674fc8/download
bitstream.checksum.fl_str_mv 427d86e5082938b801bff32bd76dd62a
e9c85981a75d21ef41720af3caf28aac
b2825df9f458e9d5d96ee8b7cd74fde6
5643bfd9bcf29d560eeec56d584edaa9
1e05ef9cd2dcbbca2af363510f374dd9
b844eeca37846b65fa8034ba5141ddcf
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390619965423616
spelling Cuello López, Javier Mauricioe8444c6d-2db4-4fae-b789-729d45658e49-1Cuello López, MariluzFidalgo Zapata, AnaLópez Agudelo, LauraCuello López, Javier MauricioEspecialista en Epidemiología (en Convenio con el CES)Especialista en EpidemiologíaEspecializaciónFull timeda211e17-b3ec-408c-9f76-43024074fccc-170f187df-929b-426b-8d83-c66a68d8c36e-142634184-6249-41a9-8f14-2fff0f65e6a0-1ae26f6c2-e6f4-48de-8f7c-5f817db16e47-12023-11-08T13:10:13Z2023-11-08T13:10:13Z2023-10-31Introducción: el cáncer de mama, es una enfermedad heterogénea, con diferentes grados de agresividad, que dependen de su expresión fenotípica, destacándose el comportamiento de los receptores hormonales y Her2, que contribuyen finalmente a la respuesta al tratamiento y pronóstico de la enfermedad. Métodos: el objetivo principal de este estudio analítico, retrospectivo de cohorte histórica fue evaluar el valor pronostico del receptor progesterona en pacientes diagnosticadas con cáncer de mama luminal manejadas con quimioterapia neoadyuvante. Resultados: en un tiempo de seguimiento de 7,5 años, se estudiaron 178 pacientes, en su mayoría con fenotipo ER+/PR- (79,2%), sin embargo, no se observaron diferencias estadísticamente significativas en estos grupos a excepción del índice de enfermedad residual RDBN en el análisis multivariado para la evaluación pronostica del receptor de progesterona. Conclusión: En pacientes con cáncer de mama subtipo luminal tratadas con quimioterapia neoadyuvante, el estado del receptor de progesterona no se asoció como factor pronóstico de supervivencia.Abstract: breast cancer is a heterogeneous disease, with different degrees of aggressiveness, which depends on its phenotypic expression, highlighting the behavior of hormone receptors and Her2, which will ultimately contribute to the response to treatment and prognosis of the disease. Methods: The main objective of this analytical, retrospective historical cohort study was to evaluate the prognostic value of the progesterone receptor in patients diagnosed with luminal breast cancer managed with neoadjuvant chemotherapy. Results: in a follow-up time of 7.5 years, 178 patients were studied, mostly with ER+/PR- phenotype (79.2%), however, no statistically significant differences were observed in these, except for the index of RDBN residual disease in multivariate analysis for progesterone receptor prognostic assessment. Conclusion: In patients with luminal subtype breast cancer treated with neoadjuvant chemotherapy, progesterone receptor status was not associated as a prognostic factor for survival.61 ppapplication/pdfhttps://repository.urosario.edu.co/handle/10336/41492spaUniversidad del RosarioUniversidad CES. Facultad de MedicinaUniversidad de CES. Facultad de medicinaEscuela de Medicina y Ciencias de la SaludEspecialización en EpidemiologíaAttribution-NonCommercial-ShareAlike 4.0 InternationalBloqueado (Texto referencial)EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.http://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_14cb Kamińska, Marzena; Ciszewski, Tomasz; Łopacka-Szatan, Karolina; Miotła, Paweł; Starosławska, Elzbieta (2015) Breast cancer risk factors. En:Przeglad Menopauzalny; Vol. 14; No. 3; pp. 196 - 202; Disponible en: 10.5114/pm.2015.54346. Weiss, Anna; Chavez-MacGregor, Mariana; Lichtensztajn, Daphne Y.; Yi, Min; Tadros, Audree; Hortobagyi, Gabriel N.; Giordano, Sharon H.; Hunt, Kelly K.; Mittendorf, Elizabeth A. (2018) Validation study of the American joint committee on cancer eighth edition prognostic stage compared with the anatomic stage in breast cancer. En:JAMA Oncology; Vol. 4; No. 2; pp. 203 - 209; Disponible en: 10.1001/jamaoncol.2017.4298. Troxell, Megan L; Gupta, Tanya (2023) Neoadjuvant Therapy in Histologic Changes and Clinical Implications. En:Surgical Pathology; Vol. 15; No. 1; pp. 57 - 75; Elsevier Inc.; Disponible en: https://doi.org/10.1016/j.path.2021.11.004. Disponible en: 10.1016/j.path.2021.11.004. Tan, Puay Hoon; Ellis, Ian; Allison, Kimberly; Brogi, Edi; Fox, Stephen B.; Lakhani, Sunil; Lazar, Alexander J.; Morris, Elizabeth A.; Sahin, Aysegul; Salgado, Roberto; Sapino, Anna; Sasano, Hironobu; Schnitt, Stuart; Sotiriou, Christos; van Diest, Paul; White, Valerie A.; Lokuhetty, Dilani; Cree, Ian A. (2020) The 2019 World Health Organization classification of tumours of the breast. En:Histopathology; Vol. 77; No. 2; pp. 181 - 185; Disponible en: 10.1111/his.14091. Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Martin, Miguel; Press, Michael; Mackey, John; Glaspy, John; Chan, Arlene; Pawlicki, Marek; Pinter, Tamas; Valero, Vicente; Liu, Mei-Ching; Sauter, Guido; Minckwitz, Gunter von; Visco, Frances; Bee, Valerie; Buyse, Marc; Bendahmane, Belguendouz; Tabah-Fisch, Isabelle; Lindsay, Mary-Ann; Riva, Alessandro; F, John Crown .; Group*, Breast Cancer International Research (2011) Adjuvant Trastuzumab in HER2-Positive Breast Cancer. En:New England Journal of Medicine; Vol. 365; pp. 687 - 696; Agnese, Doreen; Burns, Jennifer; Giordano, Sharon H; Kumar, Rashmi (2019) Breast Cancer. En:Nccn; Vol. 2; No. 0; pp. 215 - 215; De Cicco, Paola; Catani, Maria Valeria; Gasperi, Valeria; Sibilano, Matteo; Quaglietta, Maria; Savini, Isabella (2019) Nutrition and breast cancer: A literature review on prevention, treatment and recurrence. En:Nutrients; Vol. 11; No. 7; pp. 1 - 28; Disponible en: 10.3390/nu11071514. De Azambuja, E.; Cardoso, F.; De Castro, G.; Colozza, M.; Mano, M. S.; Durbecq, V.; Sotiriou, C.; Larsimont, D.; Piccart-Gebhart, M. J.; Paesmans, M. (2007) Ki-67 as prognostic marker in early breast cancer: A meta-analysis of published studies involving 12 155 patients. En:British Journal of Cancer; Vol. 96; No. 10; pp. 1504 - 1513; Disponible en: 10.1038/sj.bjc.6603756. Varsanik, Mary A; Shubeck, Sarah P (2023) De. Vol. 103; pp. 83 - 92; Disponible en: 10.1016/j.suc.2022.08.005. Niemeyer Hultstrand, Jenny; Gemzell-Danielsson, Kristina; Kallner, Helena Kopp; Lindman, Henrik; Wikman, Per; Sundström-Poromaa, Inger (2022) Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15–34 years of age: A nationwide register-based study. En:The Lancet Regional Health; Vol. 21; Disponible en: 10.1016/j.lanepe.2022.100470. Horwitz, Kathryn B.; Sartorius, Carol A. (2020) Progesterone and progesterone receptors in breast cancer: Past, present, future. En:Journal of Molecular Endocrinology; Vol. 65; No. 1; pp. T49 - T63; Disponible en: 10.1530/JME-20-0104. Lee, Jin Sun; Yost, Susan E.; Yuan, Yuan (2020) Neoadjuvant treatment for triple negative breast cancer: Recent progresses and challenges. En:Cancers; Vol. 12; No. 6; Disponible en: 10.3390/cancers12061404. Lashen, Ayat G.; Toss, Michael S.; Mongan, Nigel P.; Green, Andrew R.; Rakha, Emad A. (2023) The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long-term follow-up. En:Cancer; No. December 2022; pp. 1183 - 1194; Disponible en: 10.1002/cncr.34655. Lin, Nancy U.; Claus, Elizabeth; Sohl, Jessica; Razzak, Abdul R.; Arnaout, Amal; Winer, Eric P. (2006) Sites of Distant Relapse and Clinical Outcomes in Patients with Metastatic Triple-Negative Breast Cancer: High Incidence of Central Nervous System Metastases. En:Bone; Vol. 23; No. 1; pp. 1 - 7; 6176321972; Disponible en: 10.1002/cncr.23930.Sites. Wolff, Antonio C.; Hammond, M. Elizabeth H.; Hicks, David G.; Dowsett, Mitch; McShane, Lisa M.; Allison, Kimberly H.; Allred, Donald C.; Bartlett, John M.S.; Bilous, Michael; Fitzgibbons, Patrick; Hanna, Wedad; Jenkins, Robert B.; Mangu, Pamela B.; Paik, Soonmyung; Perez, Edith A.; Press, Michael F.; Spears, Patricia A.; Vance, Gail H.; Viale, Giuseppe; Hayes, Daniel F. (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast. En:Journal of Clinical Oncology; Vol. 31; No. 31; pp. 3997 - 4013; Disponible en: 10.1200/JCO.2013.50.9984. Derakhshan, Fatemeh; Reis-Filho, Jorge S. (2021) Pathogenesis of Triple-Negative Breast Cancer. En:Annual Review of Pathology: Mechanisms of Disease; Vol. 17; pp. 181 - 204; Disponible en: 10.1146/annurev-pathol-042420-093238. Rivera, Donna R.; Ganz, Patricia A.; Weyrich, Meghan S.; Bandos, Hanna; Melnikow, Joy (2018) Chemotherapy-Associated Peripheral Neuropathy in Patients with Early-Stage Breast Cancer: A Systematic Review. En:Journal of the National Cancer Institute; Vol. 110; No. 2; Disponible en: 10.1093/jnci/djx140. Waks, Adrienne G.; Winer, Eric P. (2019) Breast Cancer Treatment: A Review. En:JAMA; Vol. 321; No. 3; pp. 288 - 300; Disponible en: 10.1001/jama.2018.19323. Ross, Jeffrey S.; Slodkowska, Elzbieta A.; Symmans, W. Fraser; Pusztai, Lajos; Ravdin, Peter M.; Hortobagyi, Gabriel N. (2009) The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine. En:The Oncologist; Vol. 14; No. 4; pp. 320 - 368; Disponible en: 10.1634/theoncologist.2008-0230. Grabinski, Victoria F.; Brawley, Otis W. (2022) Disparities in Breast Cancer. En:Obstetrics and Gynecology Clinics of North America; Vol. 49; No. 1; pp. 149 - 165; Elsevier Inc.; Disponible en: https://doi.org/10.1016/j.ogc.2021.11.010. Disponible en: 10.1016/j.ogc.2021.11.010. Dowsett, Mitch; Cuzick, Jack; Wale, Chris; Howell, Tony; Houghton, Joan; Baum, Michael (2005) Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: An hypothesis-generating study. En:Journal of Clinical Oncology; Vol. 23; No. 30; pp. 7512 - 7517; Disponible en: 10.1200/JCO.2005.01.4829. Luporsi, Elisabeth; André, Fabrice; Spyratos, Frédérique; Martin, Pierre Marie; Jacquemier, Jocelyne; Penault-Llorca, Frédérique; Tubiana-Mathieu, Nicole; Sigal-Zafrani, Brigitte; Arnould, Laurent; Gompel, Anne; Egele, Caroline; Poulet, Bruno; Clough, Krishna B.; Crouet, Hubert; Fourquet, Alain; Lefranc, Jean Pierre; Mathelin, Carole; Rouyer, Nicolas; Serin, Daniel; Spielmann, Marc; Haugh, Margaret; Chenard, Marie Pierre; Brain, Etienne; De Cremoux, Patricia; Bellocq, Jean Pierre (2012) Ki-67: Level of evidence and methodological considerations for its role in the clinical management of breast cancer: Analytical and critical review. En:Breast Cancer Research and Treatment; Vol. 132; No. 3; pp. 895 - 915; Disponible en: 10.1007/s10549-011-1837-z. Kunkler, Ian H; Williams, Linda J; Jack, Wilma; Cameron, David A; Dixon, Michael (2021) Abstract GS2-03: Prime 2 randomised trial (postoperative radiotherapy in minimum-risk elderly): Wide local excision and adjuvant hormonal therapy +/- whole breast irradiation in women =/> 65 years with early invasive breast cancer: 10 year results. En:Cancer Research; Vol. 81; No. 4_Supplement; pp. GS2 - 03-GS2-03; Disponible en: https://doi.org/10.1158/1538-7445.SABCS20-GS2-03. Disponible en: 10.1158/1538-7445.SABCS20-GS2-03. Allison, Kimberly H.; Hammond, M. Elizabeth H.; Dowsett, Mitchell; McKernin, Shannon E.; Carey, Lisa A.; Fitzgibbons, Patrick L.; Hayes, Daniel F.; Lakhani, Sunil R.; Chavez-MacGregor, Mariana; Perlmutter, Jane; Perou, Charles M.; Regan, Meredith M.; Rimm, David L.; Symmans, W. Fraser; Torlakovic, Emina E.; Varella, Leticia; Viale, Giuseppe; Weisberg, Tracey F.; McShane, Lisa M.; Wolff, Antonio C. (2020) Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. En:Journal of Clinical Oncology; Vol. 38; No. 12; pp. 1346 - 1366; Disponible en: 10.1200/JCO.19.02309. Barzaman, Khadijeh; Karami, Jafar; Zarei, Zeinab; Hosseinzadeh, Aysooda; Kazemi, Mohammad Hossein; Moradi-Kalbolandi, Shima; Safari, Elahe; Farahmand, Leila (2020) Breast cancer: Biology, biomarkers, and treatments. En:International Immunopharmacology; Vol. 84; No. April; Disponible en: 10.1016/j.intimp.2020.106535. Chen, Chunfa; Zhang, Yuling; Huang, Ziyi; Wu, Jundong; Huang, Wenhe; Zhang, Guojun (2019) Decrease in the Ki67 index during neoadjuvant chemotherapy predicts favorable relapse-free survival in patients with locally advanced breast cancer. En:Cancer Biology and Medicine; Vol. 16; No. 3; pp. 575 - 586; Disponible en: 10.20892/j.issn.2095-3941.2018.0423. Medina, Mauricio A.; Oza, Goldie; Sharma, Ashutosh; Arriaga, L. G.; Hernández, José Manuel Hernández; Rotello, Vincent M.; Ramirez, Jose Tapia (2020) Triple-negative breast cancer: A review of conventional and advanced therapeutic strategies. En:International Journal of Environmental Research and Public Health; Vol. 17; No. 6; pp. 1 - 32; Disponible en: 10.3390/ijerph17062078. Fei, Fei; Siegal, Gene P.; Wei, Shi (2022) Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers. En:Clinical Breast Cancer; Vol. 22; No. 7; pp. e788 - e797; Elsevier Inc.; Disponible en: https://doi.org/10.1016/j.clbc.2022.07.001. Disponible en: 10.1016/j.clbc.2022.07.001. Edge, Stephen B.; Compton, Carolyn C. (2010) The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. En:Annals of Surgical Oncology; Vol. 17; No. 6; pp. 1471 - 1474; Disponible en: 10.1245/s10434-010-0985-4. Sheibani, Mohammad; Azizi, Yaser; Shayan, Maryam; Nezamoleslami, Sadaf; Eslami, Faezeh; Farjoo, Mohammad Hadi; Dehpour, Ahmad Reza (2022) Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches. En:Cardiovascular Toxicology; Vol. 22; No. 4; pp. 292 - 310; Springer US; Disponible en: https://doi.org/10.1007/s12012-022-09721-1. Disponible en: 10.1007/s12012-022-09721-1. Jafari, Seyed Hamed; Saadatpour, Zahra; Salmaninejad, Arash; Momeni, Fatemeh; Mokhtari, Mojgan; Nahand, Javid Sadri; Rahmati, Majid; Mirzaei, Hamed; Kianmehr, Mojtaba (2018) Breast cancer diagnosis: Imaging techniques and biochemical markers. En:Journal of Cellular Physiology; Vol. 233; No. 7; pp. 5200 - 5213; Disponible en: 10.1002/jcp.26379. Di Nardo, Paola; Lisanti, Camilla; Garutti, Mattia; Buriolla, Silvia; Alberti, Martina; Mazzeo, Roberta; Puglisi, Fabio (2022) Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects. En:Expert Opinion on Drug Safety; Vol. 21; No. 11; pp. 1341 - 1355; Taylor & Francis; Disponible en: https://doi.org/10.1080/14740338.2022.2151584. Disponible en: 10.1080/14740338.2022.2151584. Emens, Leisha A (2018) Breast Cancer Immunotherapy: Facts and Hopes. En:Clinical Cancer Research; Vol. 24; No. 3; pp. 511 - 520; Disponible en: file:///C:/Users/Carla%0ACarolina/Desktop/Artigos%0Apara%0Aacrescentar%0Ana%0Aqualificação/The%0Aimpact%0Aof%0Abirth%0Aweight%0Aon%0Acardiovascular%0Adisease%0Arisk%0Ain. Disponible en: 10.1158/1078-0432.CCR-16-3001.Breast. Shaaban, Abeer M.; Provenzano, Elena (2022) Receptor Status after Neoadjuvant Therapy of Breast Cancer: Significance and Implications. En:Pathobiology; Vol. 89; No. 5; pp. 297 - 308; Disponible en: 10.1159/000521880. O’Brien, Katie M; Cole, Stephen R; Tse, Chiu-Kit; Perou, Charles M; Carey, Lisa A; Foulkes, William D; Dressler, Lynn G.; Geradts, Joseph; Millikan, Robert C (2011) Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. En:Bone; Vol. 23; No. 1; pp. 1 - 7; 6176321972; Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf. Disponible en: 10.1158/1078-0432.CCR-10-1533.Intrinsic. Russo, Jose; Moral, Raquel; Balogh, Gabriela A.; Mailo, Daniel; Russo, Irma H. (2005) The protective role of pregnancy in breast cancer. En:Breast Cancer Research; Vol. 7; No. 3; pp. 131 - 142; Disponible en: 10.1186/bcr1029. International Agency for Research on Cancer (2018) Estimated number of incident cases stomach, both sexes, all ages. Vol. 33; No. 0; pp. 800 - 800; Disponible en: https://gco.iarc.fr/today/online-analysis-multi-bars?v=2018&mode=population&mode_population=countries&population=900&populations=900&key=total&sex=0&cancer=7&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_item. Yin, Li; Duan, Jiang Jie; Bian, Xiu Wu; Yu, Shi Cang (2020) Triple-negative breast cancer molecular subtyping and treatment progress. En:Breast Cancer Research; Vol. 22; No. 1; pp. 1 - 13; Breast Cancer Research; Disponible en: 10.1186/s13058-020-01296-5. Rastogi, Priya; Anderson, Stewart J.; Bear, Harry D.; Geyer, Charles E.; Kahlenberg, Morton S.; Robidoux, André; Margolese, Richard G.; Hoehn, James L.; Vogel, Victor G.; Dakhil, Shaker R.; Tamkus, Deimante; King, Karen M.; Pajon, Eduardo R.; Wright, Mary Johanna; Robert, Jean; Paik, Soonmyung; Mamounas, Eleftherios P.; Wolmark, Norman (2008) Preoperative chemotherapy: Updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. En:Journal of Clinical Oncology; Vol. 26; No. 5; pp. 778 - 785; Disponible en: 10.1200/JCO.2007.15.0235. Harbeck, Nadia; Penault-Llorca, Frédérique; Cortes, Javier; Gnant, Michael; Houssami, Nehmat; Poortmans, Philip; Ruddy, Kathryn; Tsang, Janice; Cardoso, Fatima (2019) Breast cancer. En:Nature Reviews Disease Primers; Vol. 5; No. 1; 0123456789; Disponible en: 10.1038/s41572-019-0111-2. Raj-Kumar, Praveen Kumar; Liu, Jianfang; Hooke, Jeffrey A.; Kovatich, Albert J.; Kvecher, Leonid; Shriver, Craig D.; Hu, Hai (2019) PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B. En:Scientific Reports; Vol. 9; No. 1; pp. 1 - 13; Disponible en: 10.1038/s41598-019-44339-4. Loibl, Sibylle; Gianni, Luca (2017) HER2-positive breast cancer. En:The Lancet; Vol. 389; No. 10087; pp. 2415 - 2429; Elsevier Ltd; Disponible en: http://dx.doi.org/10.1016/S0140-6736(16)32417-5. Disponible en: 10.1016/S0140-6736(16)32417-5. Moskowitz, Chaya S.; Chou, Joanne F.; Wolden, Suzanne L.; Bernstein, Jonine L.; Malhotra, Jyoti; Friedman, Danielle Novetsky; Mubdi, Nidha Z.; Leisenring, Wendy M.; Stovall, Marilyn; Hammond, Sue; Smith, Susan A.; Henderson, Tara O.; Boice, John D.; Hudson, Melissa M.; Diller, Lisa R.; Bhatia, Smita; Kenney, Lisa B.; Neglia, Joseph P.; Begg, Colin B.; Robison, Leslie L.; Oeffinger, Kevin C. (2014) Breast cancer after chest radiation therapy for childhood cancer. En:Journal of Clinical Oncology; Vol. 32; No. 21; pp. 2217 - 2223; Disponible en: 10.1200/JCO.2013.54.4601. Chang, Jung Min; Leung, Jessica W.T.; Moy, Linda; Ha, Su Min; Moon, Woo Kyung (2020) Axillary nodal evaluation in breast cancer: State of the art. En:Radiology; Vol. 295; No. 3; pp. 500 - 515; Disponible en: 10.1148/radiol.2020192534. Silber, Jeffrey H.; Rosenbaum, Paul R.; Clark, Amy S.; Giantonio, Bruce J.; Ross, Richard N.; Teng, Yun; Wang, Min; Niknam, Bijan A.; Ludwig, Justin M.; Wang, Wei; Even-Shoshan, Orit; Fox, Kevin R. (2013) Characteristics associated with differences in survival among black and white women with breast cancer. En:Jama; Vol. 310; No. 4; pp. 389 - 397; Disponible en: 10.1001/jama.2013.8272. Patani, Neill; Martin, Lesley Ann; Dowsett, Mitch (2013) Biomarkers for the clinical management of breast cancer: International perspective. En:International Journal of Cancer; Vol. 133; No. 1; pp. 1 - 13; Disponible en: 10.1002/ijc.27997. Sharma, Anita; Ives, Charlotte (2022) Management of breast cancer: basic principles. En:Surgery (United Kingdom); Vol. 40; No. 2; pp. 113 - 120; Elsevier Ltd; Disponible en: https://doi.org/10.1016/j.mpsur.2021.11.020. Disponible en: 10.1016/j.mpsur.2021.11.020. Deng, Chu Xia (2006) BRCA1: Cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. En:Nucleic Acids Research; Vol. 34; No. 5; pp. 1416 - 1426; Disponible en: 10.1093/nar/gkl010. Bauer, Anderson (2023) Radiation Treatment for Breast Cancer. En:Surgical Clinics of North America; Vol. 103; No. 1; pp. 187 - 199; Elsevier Inc.; Disponible en: https://doi.org/10.1016/j.suc.2022.08.015. Disponible en: 10.1016/j.suc.2022.08.015. Dieci, Maria V; Orieto, Enrico; Dominici, Massimo; Conte, Pierfranco; Guarner, Valentina (2014) Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities. En:The Oncologist; pp. 805 - 813; Li, Lun; Han, Dongdong; Wang, Xiaowei; Wang, Quan; Tian, Jinhui; Yao, Jia; Yuan, Liqin; Qian, Ke; Zou, Qiongyan; Yi, Wenjun; Zhou, Enxiang; Yang, Kehu (2017) Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: A systematic review and meta-analysis. En:Future Oncology; Vol. 13; No. 11; pp. 1021 - 1034; Disponible en: 10.2217/fon-2016-0428. Fei, Li, MD; Bei, Wang, MD; Hongyu, Ding, MD; Hongjun, Sun, MD (2018) Sonographic Features of Triple Negative Breast Cancer. En:Advanced Ultrasound in Diagnosis and Therapy; Vol. 2; No. 1; pp. 18 - 18; 0000000000; Disponible en: 10.37015/audt.2018.180005. Dauphine, Christine; Moazzez, Ashkan; Neal, Jasmin C.; Chlebowski, Rowan T.; Ozao-Choy, Junko (2020) Single Hormone Receptor-Positive Breast Cancers Have Distinct Characteristics and Survival. En:Annals of Surgical Oncology; Vol. 27; No. 12; pp. 4687 - 4694; Springer International Publishing; Disponible en: https://doi.org/10.1245/s10434-020-08898-5. Disponible en: 10.1245/s10434-020-08898-5. Watkins, Elyse J. (2019) Overview of breast cancer. En:Journal of the American Academy of Physician Assistants; Vol. 32; No. 10; pp. 13 - 17; Disponible en: 10.1097/01.JAA.0000580524.95733.3d. Keenan, Tanya; Moy, Beverly; Mroz, Edmund A.; Ross, Kenneth; Niemierko, Andrzej; Rocco, James W.; Isakoff, Steven; Ellisen, Leif W.; Bardia, Aditya (2015) Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrence. En:Journal of Clinical Oncology; Vol. 33; No. 31; pp. 3621 - 3627; Disponible en: 10.1200/JCO.2015.62.2126. Kim, Byoung Hyuck; Shin, Kyung Hwan; Chie, Eui Kyu; Kim, Jin Ho; Kim, Kyubo; Hwang, Ki Tae; Kim, Jongjin; Choi, In Sil; Park, Jin Hyun; Kim, Suzy (2020) Identifying long-term survival candidates among patients with isolated locoregionally recurrent breast cancer: Implications of the use of systemic chemotherapy. En:Journal of Breast Cancer; Vol. 23; No. 3; pp. 279 - 290; 0000000171618; Disponible en: 10.4048/jbc.2020.23.e31. Wang, Huan; Mao, Xiaoyun (2020) Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer. En:Drug Design, Development and Therapy; Vol. 14; pp. 2423 - 2433; Disponible en: 10.2147/DDDT.S253961. Prat, Aleix; Perou, Charles M. (2011) Deconstructing the molecular portraits of breast cancer. En:Molecular Oncology; Vol. 5; No. 1; pp. 5 - 23; Disponible en: 10.1016/j.molonc.2010.11.003. Tian, Hao; Ma, Dandan; Tan, Xuanni; Yan, Wenting; Wu, Xiujuan; He, Cheng; Zhong, Ling; Zhang, Yan; Yu, Bingjie; Zhang, Yi; Qi, Xiaowei (2021) Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review. En:Frontiers in Pharmacology; Vol. 12; No. December; pp. 1 - 13; Disponible en: 10.3389/fphar.2021.770663. Li, Zhuo; Wei, Hongrui; Li, Siyan; Wu, Pei; Mao, Xiaoyun (2022) The Role of Progesterone Receptors in Breast Cancer. No. January; pp. 305 - 314; Cserni, G; Quinn, Cecily M; Foschini, Maria Pia; Bianchi, Simonetta; Callagy, Grace; Chmielik, Ewa; Decker, Thomas; Fend, Falko; Diest, Paul J Van; Ellis, Ian O (2021) Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis. En:Cancers; pp. 1 - 23; Carey, Lisa A.; Dees, E. Claire; Sawyer, Lynda; Gatti, Lisa; Moore, Dominic T.; Collichio, Frances; Ollila, David W.; Sartor, Carolyn I.; Graham, Mark L.; Perou, Charles M. (2007) The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes. En:Clinical Cancer Research; Vol. 13; No. 8; pp. 2329 - 2334; Disponible en: 10.1158/1078-0432.CCR-06-1109. Finkelman, Brian S.; Zhang, Huina; Hicks, David G.; Turner, Bradley M. (2023) The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations. En:Cancers; Vol. 15; No. 3; Disponible en: 10.3390/cancers15030808. Voduc, K David; Cheang, Maggie C U; Tyldesley, Scott; Gelmon, Karen; Nielsen, Torsten O (2023) Breast Cancer Subtypes and the Risk of Local and Regional Relapse. En:Journal of Clinical Oncology; Vol. 28; No. 10; Disponible en: 10.1200/JCO.2009.24.9284. Coughlin, Steven S. (2019) Social determinants of breast cancer risk, stage, and survival. En:Breast Cancer Research and Treatment; Vol. 177; No. 3; pp. 537 - 548; Springer US; 0123456789; Disponible en: https://doi.org/10.1007/s10549-019-05340-7. Disponible en: 10.1007/s10549-019-05340-7. Eisenhauer, E. A.; Therasse, P.; Bogaerts, J.; Schwartz, L. H.; Sargent, D.; Ford, R.; Dancey, J.; Arbuck, S.; Gwyther, S.; Mooney, M.; Rubinstein, L.; Shankar, L.; Dodd, L.; Kaplan, R.; Lacombe, D.; Verweij, J. (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). En:European Journal of Cancer; Vol. 45; No. 2; pp. 228 - 247; Elsevier Ltd; Disponible en: http://dx.doi.org/10.1016/j.ejca.2008.10.026. Disponible en: 10.1016/j.ejca.2008.10.026. Zhang, Song; Zhang, Dong; Yi, Shanhong; Gong, Mingfu; Lu, Caibao; Cai, Yuanqing; Tang, Xuefeng; Zou, Liguang (2017) The relationship of lymphatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: A systematic review and meta-analysis. En:Oncotarget; Vol. 8; No. 2; pp. 2863 - 2873; Disponible en: 10.18632/oncotarget.13752. Sun, Yi Sheng; Zhao, Zhao; Yang, Zhang Nv; Xu, Fang; Lu, Hang Jing; Zhu, Zhi Yong; Shi, Wen; Jiang, Jianmin; Yao, Ping Ping; Zhu, Han Ping (2017) Risk factors and preventions of breast cancer. En:International Journal of Biological Sciences; Vol. 13; No. 11; pp. 1387 - 1397; Disponible en: 10.7150/ijbs.21635. Lambertini, Matteo; Pinto, Ana Catarina; Ameye, Lieveke; Jongen, Lynn; Del Mastro, Lucia; Puglisi, Fabio; Poggio, Francesca; Bonotto, Marta; Floris, Giuseppe; Van Asten, Kathleen; Wildiers, Hans; Neven, Patrick; De Azambuja, Evandro; Paesmans, Marianne; Azim, Hatem A. (2016) The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients. En:British Journal of Cancer; Vol. 115; No. 12; pp. 1471 - 1478; Nature Publishing Group; Disponible en: http://dx.doi.org/10.1038/bjc.2016.359. Disponible en: 10.1038/bjc.2016.359. Shaikh, Naseer Ahmed; Rajput, M. Jawaid Aqeel; Samo, Rukhsana; Soomro, Rasheed Ahmed (2018) Breast Cancer. En:The Professional Medical Journal; Vol. 21; No. 02; pp. 373 - 376; Disponible en: 10.29309/tpmj/2014.21.02.1986. Cortazar, Patricia; Zhang, Lijun; Untch, Michael; Mehta, Keyur; Costantino, Joseph P.; Wolmark, Norman; Bonnefoi, Hervé; Cameron, David; Gianni, Luca; Valagussa, Pinuccia; Swain, Sandra M.; Prowell, Tatiana; Loibl, Sibylle; Wickerham, D. Lawrence; Bogaerts, Jan; Baselga, Jose; Perou, Charles; Blumenthal, Gideon; Blohmer, Jens; Mamounas, Eleftherios P.; Bergh, Jonas; Semiglazov, Vladimir; Justice, Robert; Eidtmann, Holger; Paik, Soonmyung; Piccart, Martine; Sridhara, Rajeshwari; Fasching, Peter A.; Slaets, Leen; Tang, Shenghui; Gerber, Bernd; Geyer, Charles E.; Pazdur, Richard; Ditsch, Nina; Rastogi, Priya; Eiermann, Wolfgang; Von Minckwitz, Gunter (2014) Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis. En:The Lancet; Vol. 384; No. 9938; pp. 164 - 172; Disponible en: 10.1016/S0140-6736(13)62422-8. Kashyap, Dharambir; Pal, Deeksha; Sharma, Riya; Garg, Vivek Kumar; Goel, Neelam; Koundal, Deepika; Zaguia, Atef; Koundal, Shubham; Belay, Assaye (2022) Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. En:BioMed Research International; Vol. 2022; Disponible en: 10.1155/2022/9605439. Pathmanathan, Nirmala; Balleine, Rosemary L.; Jayasinghe, Upali W.; Bilinski, Kellie L.; Provan, Pamela J.; Byth, Karen; Bilous, A. Michael; Salisbury, Elizabeth L.; Boyages, John (2014) The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. En:Journal of Clinical Pathology; Vol. 67; No. 3; pp. 222 - 228; Disponible en: 10.1136/jclinpath-2013-201793. Dine, Jennifer; Deng, Chu Xia (2013) Mouse models of BRCA1 and their application to breast cancer research. En:Cancer and Metastasis Reviews; Vol. 32; No. 1-2; pp. 25 - 37; 1055501294037; Disponible en: 10.1007/s10555-012-9403-7. Foulkes, William D.; Grainge, Matthew J.; Rakha, Emad A.; Green, Andrew R.; Ellis, Ian O. (2009) Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status. En:Breast Cancer Research and Treatment; Vol. 117; No. 1; pp. 199 - 204; Disponible en: 10.1007/s10549-008-0102-6. Teal, Stephanie; Edelman, Alison (2021) Contraception Selection, Effectiveness, and Adverse Effects: A Review. En:JAMA; Vol. 326; No. 24; pp. 2507 - 2518; Disponible en: 10.1001/jama.2021.21392. Tan, Shirong; Fu, Xin; Xu, Shouping; Qiu, Pengfei; Lv, Zhidong; Xu, Yingying; Zhang, Qiang (2021) Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy. En:Pathology and Oncology Research; Vol. 27; No. December; pp. 1 - 16; Disponible en: 10.3389/pore.2021.1609972. Hou, Yanjun; Peng, Yan; Li, Zaibo (2022) Update on prognostic and predictive biomarkers of breast cancer. En:Seminars in Diagnostic Pathology; Vol. 39; No. 5; pp. 322 - 332; Elsevier Inc.; Disponible en: https://doi.org/10.1053/j.semdp.2022.06.015. Disponible en: 10.1053/j.semdp.2022.06.015. Lin, Canling; Cui, Jiajun; Peng, Zhen; Qian, Kai; Wu, Runwen; Cheng, Yimin; Yin, Weihua (2022) Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis. En:European Journal of Medical Research; Vol. 27; No. 1; pp. 1 - 11; BioMed Central; Disponible en: https://doi.org/10.1186/s40001-022-00839-0. Disponible en: 10.1186/s40001-022-00839-0. Dunn, Barbara K.; Agurs-Collins, Tanya; Browne, Doris; Lubet, Ronald; Johnson, Karen A. (2010) Health disparities in breast cancer: Biology meets socioeconomic status. En:Breast Cancer Research and Treatment; Vol. 121; No. 2; pp. 281 - 292; Disponible en: 10.1007/s10549-010-0827-x. Tonellotto, Fabiana; Bergmann, Anke; Abrahao, Karen de Souza; Sales de Aguiar, Suzana; Adeodato Bello, Marcelo; Santos Thuler, Luiz Claudio (2019) Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer. En:European Journal of Breast Health; Vol. 15; No. 2; pp. 76 - 84; Disponible en: 10.5152/ejbh.2019.4414. Masood, Shahla (2016) Neoadjuvant chemotherapy in breast cancers. Disponible en: 10.1177/1745505716677139. Łukasiewicz, Sergiusz; Czeczelewski, Marcin; Forma, Alicja; Baj, Jacek; Sitarz, Robert; Stanisławek, Andrzej (2021) Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review. En:Cancers; Vol. 13; No. 17; pp. 4287 - 4287; Disponible en: https://www.mdpi.com/2072-6694/13/17/4287. Disponible en: 10.3390/cancers13174287. Zhou, Liheng; Xu, Shuguang; Yin, Wenjin; Lin, Yanpin; Du, Yueyao; Jiang, Yiwei; Wang, Yaohui; Zhang, Jie; Wu, Ziping; Lu, Jinsong (2017) Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: A prospective, single arm, phase II study. En:Oncotarget; Vol. 8; No. 45; pp. 79305 - 79314; Disponible en: 10.18632/oncotarget.17954. Thakkar, Jigisha P.; Mehta, Divyesh G. (2011) A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative. En:The Oncologist; Vol. 16; No. 3; pp. 276 - 285; Disponible en: 10.1634/theoncologist.2010-0302. Liu, Yin; He, Min; Zuo, Wen Jia; Hao, Shuang; Wang, Zhong Hua; Shao, Zhi Ming (2021) Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement. En:Frontiers in Oncology; Vol. 11; No. April; pp. 1 - 7; Disponible en: 10.3389/fonc.2021.585613. Freelander, Allegra; Brown, Lauren J; Parker, Andrew; Segara, Davendra; Portman, Neil; Lau, Brandon; Lim, Elgene (2021) Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer. Palma, Giuseppe; Frasci, Giuseppe; Chirico, Andrea; Esposito, Emanuela; Siani, Claudio; Saturnino, Carmela; Arra, Claudio; Ciliberto, Gennaro; Giordano, Antonio; D'Aiuto, Massimiliano (2015) Triple negative breast cancer: Looking for the missing link between biology and treatments. En:Oncotarget; Vol. 6; No. 29; pp. 26560 - 26574; Disponible en: 10.18632/oncotarget.5306. Giuliano, Armando E.; Edge, Stephen B.; Hortobagyi, Gabriel N. (2018) Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. En:Annals of Surgical Oncology; Vol. 25; No. 7; pp. 1783 - 1785; Springer International Publishing; Disponible en: https://doi.org/10.1245/s10434-018-6486-6. Disponible en: 10.1245/s10434-018-6486-6. Feng, Yixiao; Spezia, Mia; Huang, Shifeng; Yuan, Chengfu; Zeng, Zongyue; Zhang, Linghuan; Ji, Xiaojuan; Liu, Wei; Huang, Bo; Luo, Wenping; Liu, Bo; Lei, Yan; Du, Scott; Vuppalapati, Akhila; Luu, Hue H.; Haydon, Rex C.; He, Tong Chuan; Ren, Guosheng (2018) Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. En:Genes and Diseases; Vol. 5; No. 2; pp. 77 - 106; Elsevier Ltd; Disponible en: https://doi.org/10.1016/j.gendis.2018.05.001. Disponible en: 10.1016/j.gendis.2018.05.001. Hortobagyi, Gabriel N; Edge, Stephen B; Giuliano, Armando (2018) New and Important Changes in the TNM Staging System for Breast Cancer. En:American Society of Clinical Oncology Educational Book; No. 38; pp. 457 - 467; Disponible en: 10.1200/edbk_201313. Shien, Tadahiko; Iwata, Hiroji (2020) Adjuvant and neoadjuvant therapy for breast cancer. En:Japanese Journal of Clinical Oncology; Vol. 50; No. 3; pp. 225 - 229; Disponible en: 10.1093/jjco/hyz213. Al‐rashdan, Abdulla; Deban, Melina; Quan, May Lynn; Cao, Jeffrey Q. (2022) Locoregional Management of Breast Cancer: A Chronological Review. En:Current Oncology; Vol. 29; No. 7; pp. 4647 - 4664; Disponible en: 10.3390/curroncol29070369. Killelea, Brigid K.; Yang, Vicky Q.; Wang, Shi Yi; Hayse, Brandon; Mougalian, Sarah; Horowitz, Nina R.; Chagpar, Anees B.; Pusztai, Lajos; Lannin, Donald R. (2015) Racial differences in the use and outcome of neoadjuvant chemotherapy for breast cancer: Results From the National Cancer Data Base. En:Journal of Clinical Oncology; Vol. 33; No. 36; pp. 4267 - 4275; Disponible en: 10.1200/JCO.2015.63.7801. Leon-Ferre, Roberto A.; Hieken, Tina J; Boughey, Judy C (2021) The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer. En:Annals of Surgical Oncology; Vol. 28; No. 4; pp. 2111 - 2119; Disponible en: 10.1245/s10434-020-09480-9. Tsang, Julia Y S; Tse, Gary M (2020) Molecular Classification of Breast Cancer. Vol. 27; No. 1; Özdemir, Özlem; Zengel, Baha; Çavdar, Demet Kocatepe; Yilmaz, Cengiz; Durusoy, Raika (2022) Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients. En:European Journal of Breast Health; Vol. 18; No. 2; pp. 167 - 171; Disponible en: 10.4274/ejbh.galenos.2022.2022-1-4. Brawley, Otis W.; Lansey, Dina George (2023) Disparities in Breast Cancer Outcomes and How to Resolve Them. En:Hematology/Oncology Clinics of North America; Vol. 37; No. 1; pp. 1 - 15; Disponible en: 10.1016/j.hoc.2022.08.002. Giammarile, Francesco; Vidal-Sicart, Sergi; Paez, Diana; Pellet, Olivier; Enrique, Estrada Lobato; Mikhail-Lette, Miriam; Morozova, Olga; Maria Camila, Navarro Marulanda; Diana Ivonne, Rodríguez Sanchez; Delgado Bolton, Roberto C.; Valdés Olmos, Renato A.; Mariani, Giuliano (2022) Sentinel Lymph Node Methods in Breast Cancer. En:Seminars in Nuclear Medicine; Vol. 52; No. 5; pp. 551 - 560; Disponible en: 10.1053/j.semnuclmed.2022.01.006. Kaufman, Cary S (2019) Increasing Role of Oncoplastic Surgery for Breast Cancer. : Current Oncology Reports; Yerushalmi, Rinat; Woods, Ryan; Ravdin, Peter M.; Hayes, Malcolm M.; Gelmon, Karen A. (2010) Ki67 in breast cancer: prognostic and predictive potential. En:The Lancet Oncology; Vol. 11; No. 2; pp. 174 - 183; Elsevier Ltd; Disponible en: http://dx.doi.org/10.1016/S1470-2045(09)70262-1. Disponible en: 10.1016/S1470-2045(09)70262-1. Mohamed, Adel Mahjoub Musa; Alshammari, Fatimah Khalifah Ayed; Aloyatyfi, Razan Fahad Saleh; Alenazi, Khawlah Hammed Mamlooh; Alwuwaili, Amjad Mofareh S (2020) The Relationship between Hormonal Contraception and Breast Cancer. En:Archivepp.Com; Vol. 11; No. 4; pp. 124 - 129; Disponible en: https://archivepp.com/storage/models/article/EtiuefwVvngqexAAD2Xy3cVrHw1yg8mgwdJeKyvsgcR9IWRCtkcpw8z6Sjp6/the-relationship-between-hormonal-contraception-and-breast-cancer.pdf. Allison, Kimberly H.; Hammond, M. Elizabeth H.; Dowsett, Mitchell; McKernin, Shannon E.; Carey, Lisa A.; Fitzgibbons, Patrick L.; Hayes, Daniel F.; Lakhani, Sunil R.; Chavez-MacGregor, Mariana; Perlmutter, Jane; Perou, Charles M.; Regan, Meredith M.; Rimm, David L.; Symmans, W. Fraser; Torlakovic, Emina E.; Varella, Leticia; Viale, Giuseppe; Weisberg, Tracey F.; McShane, Lisa M.; Wolff, Antonio C. (2020) Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/college of American pathologists guideline update. En:Archives of Pathology and Laboratory Medicine; Vol. 144; No. 5; pp. 545 - 563; Disponible en: 10.5858/arpa.2019-0904-SA. Diana, Anna; Carlino, Francesca; Buono, Giuseppe; Antoniol, Giuliano; Famiglietti, Vincenzo; De Angelis, Carmine; Carrano, Simone; Piccolo, Antonio; De Vita, Ferdinando; Ciardiello, Fortunato; Daniele, Bruno; Arpino, Grazia; Orditura, Michele (2022) Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis. En:Frontiers in Oncology; Vol. 12; No. March; pp. 1 - 8; Disponible en: 10.3389/fonc.2022.813462. Byrski, T.; Huzarski, T.; Dent, R.; Marczyk, E.; Jasiowka, M.; Gronwald, J.; Jakubowicz, J.; Cybulski, C.; Wisniowski, R.; Godlewski, D.; Lubinski, J.; Narod, S. A. (2014) Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. En:Breast Cancer Research and Treatment; Vol. 147; No. 2; pp. 401 - 405; Disponible en: 10.1007/s10549-014-3100-x.instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCáncer de mamaReceptor de progesteronaQuimioterapia neoadyuvanteBreast NeoplasmsProgesterone receptorNeoadjuvant chemotherapyEvaluación pronóstica del receptor hormonal de progesterona en pacientes con cáncer de mama luminal tratadas con quimioterapia neoadyuvantePrognostic evaluation of the progesterone hormone receptor in patients with luminal breast cancer treated with neoadjuvant chemotherapybachelorThesisTrabajo de gradoTrabajo de gradohttp://purl.org/coar/resource_type/c_7a1fEscuela de Medicina y Ciencias de la SaludORIGINALEvaluacion_pronostica_del_receptor_horomonal.pdfEvaluacion_pronostica_del_receptor_horomonal.pdfapplication/pdf2409499https://repository.urosario.edu.co/bitstreams/37208b3b-f4f2-48e3-9eeb-ccf6d3036ca4/download427d86e5082938b801bff32bd76dd62aMD51Referencias bibliograficas.risReferencias bibliograficas.risapplication/x-research-info-systems211466https://repository.urosario.edu.co/bitstreams/8a7c580f-66f9-4044-85c2-b3ddb33c6817/downloade9c85981a75d21ef41720af3caf28aacMD53LICENSElicense.txtlicense.txttext/plain1483https://repository.urosario.edu.co/bitstreams/c2ee0dc9-dbe7-4996-a62f-0dd652d4d239/downloadb2825df9f458e9d5d96ee8b7cd74fde6MD52CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81160https://repository.urosario.edu.co/bitstreams/140b15d4-9017-40c5-98d7-19bd1afd239b/download5643bfd9bcf29d560eeec56d584edaa9MD54TEXTEvaluacion_pronostica_del_receptor_horomonal.pdf.txtEvaluacion_pronostica_del_receptor_horomonal.pdf.txtExtracted texttext/plain101378https://repository.urosario.edu.co/bitstreams/538f9059-b27e-4969-bc2b-bdb85c449f9e/download1e05ef9cd2dcbbca2af363510f374dd9MD55THUMBNAILEvaluacion_pronostica_del_receptor_horomonal.pdf.jpgEvaluacion_pronostica_del_receptor_horomonal.pdf.jpgGenerated Thumbnailimage/jpeg3038https://repository.urosario.edu.co/bitstreams/06f13e0c-5fa8-436b-b81a-6f8ec1674fc8/downloadb844eeca37846b65fa8034ba5141ddcfMD5610336/41492oai:repository.urosario.edu.co:10336/414922023-11-09 03:00:30.138http://creativecommons.org/licenses/by-nc-sa/4.0/Attribution-NonCommercial-ShareAlike 4.0 Internationalhttps://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.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

Publicaciones similares